10 Weeks Later, Kite Pharma Stock Is Up 94.40%

KITE Stock: Taking a Victory Lap Well, it didn't really take long for my bullish view on Kite Pharma stock to get vindicated. Just yesterday alone, KITE stock was trading higher by 28.48%. The catalyst driving the gains was a definitive agreement between Gilead Sciences, Inc. (NASDAQ: GILD) and Kite Pharma Inc (NASDAQ: KITE), where Gilead agreed to acquire the stock at $180.00 per share, which values the deal at $11.9 billion. This buyout price represents a 94.4% return from the price point wher...